17105236 12132928 11471488 10541370 10100704 13129395 10850321 14506184 10809213 12700943 15149193 18701282 16979440 10906734 16115934 10740655 12515879 14506192 15068616 12511412 11255079 11915167 11337558 10541367 20187791 11789023 - Search Results

Year	Number of Results
1999	4
2000	3
2001	4
2002	2
2003	6
2004	2
2005	1
2006	2
2008	1
2010	1
2023	0

1

Influence of the linker on the biodistribution and catabolism of actinium-225 self-immolative tumor-targeted isotope generators.

Antczak C, Jaggi JS, LeFave CV, Curcio MJ, McDevitt MR, Scheinberg DA. Antczak C, et al. Bioconjug Chem. 2006 Nov-Dec;17(6):1551-60. doi: 10.1021/bc060156+. Bioconjug Chem. 2006. PMID: 17105236 Free PMC article.

2

Mechanistic studies of a calcium-dependent MRI contrast agent.

Li WH, Parigi G, Fragai M, Luchinat C, Meade TJ. Li WH, et al. Inorg Chem. 2002 Jul 29;41(15):4018-24. doi: 10.1021/ic0200390. Inorg Chem. 2002. PMID: 12132928

3

Status of radioimmunotherapy in the new millennium.

Imam SK. Imam SK. Cancer Biother Radiopharm. 2001 Jun;16(3):237-56. doi: 10.1089/10849780152389429. Cancer Biother Radiopharm. 2001. PMID: 11471488 Review.

4

Dosimetry-based therapy in metastatic breast cancer patients using 90Y monoclonal antibody 170H.82 with autologous stem cell support and cyclosporin A.

Richman CM, DeNardo SJ, O'Donnell RT, Goldstein DS, Shen S, Kukis DL, Kroger LA, Yuan A, Boniface GR, Griffith IJ, DeNardo GL. Richman CM, et al. Clin Cancer Res. 1999 Oct;5(10 Suppl):3243s-3248s. Clin Cancer Res. 1999. PMID: 10541370

5

67Cu-versus 131I-labeled Lym-1 antibody: comparative pharmacokinetics and dosimetry in patients with non-Hodgkin's lymphoma.

DeNardo GL, Kukis DL, Shen S, DeNardo DA, Meares CF, DeNardo SJ. DeNardo GL, et al. Clin Cancer Res. 1999 Mar;5(3):533-41. Clin Cancer Res. 1999. PMID: 10100704

6

Conditionally cleavable radioimmunoconjugates: a novel approach for the release of radioisotopes from radioimmunoconjugates.

Beeson C, Butrynski JE, Hart MJ, Nourigat C, Matthews DC, Press OW, Senter PD, Bernstein ID. Beeson C, et al. Bioconjug Chem. 2003 Sep-Oct;14(5):927-33. doi: 10.1021/bc025655z. Bioconjug Chem. 2003. PMID: 13129395

7

Stability of monoclonal antibodies, Lym-1 and ChL6, and 2IT-BAD-Lym-1 immunoconjugate with ultra freezer storage.

Kukis DL, DeNardo SJ, Mills SL, Shen S, O'Donnell RT, DeNardo GL. Kukis DL, et al. Cancer Biother Radiopharm. 1999 Oct;14(5):363-9. doi: 10.1089/cbr.1999.14.363. Cancer Biother Radiopharm. 1999. PMID: 10850321

8

Preclinical evaluation of cathepsin-degradable peptide linkers for radioimmunoconjugates.

DeNardo GL, DeNardo SJ, Peterson JJ, Miers LA, Lam KS, Hartmann-Siantar C, Lamborn KR. DeNardo GL, et al. Clin Cancer Res. 2003 Sep 1;9(10 Pt 2):3865S-72S. Clin Cancer Res. 2003. PMID: 14506184

9

Radiation dosimetry for 90Y-2IT-BAD-Lym-1 extrapolated from pharmacokinetics using 111In-2IT-BAD-Lym-1 in patients with non-Hodgkin's lymphoma.

DeNardo GL, O'Donnell RT, Shen S, Kroger LA, Yuan A, Meares CF, Kukis DL, DeNardo SJ. DeNardo GL, et al. J Nucl Med. 2000 May;41(5):952-8. J Nucl Med. 2000. PMID: 10809213 Free article.

10

Antibody therapy of non-Hodgkin's B-cell lymphoma.

Chinn P, Braslawsky G, White C, Hanna N. Chinn P, et al. Cancer Immunol Immunother. 2003 May;52(5):257-80. doi: 10.1007/s00262-002-0347-6. Epub 2003 Feb 28. Cancer Immunol Immunother. 2003. PMID: 12700943 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results